The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1016/j.snb.2022.133046
|View full text |Cite
|
Sign up to set email alerts
|

Multifunctional nanocone array as solid immunoassay plate and SERS substrate for the early diagnosis of prostate cancer on microfluidic chip

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 35 publications
0
5
0
Order By: Relevance
“…This amplication enables the examination of biomolecules such as small compounds, large protein molecules, and even cellular entities. 127,128 In this regard, Lu et al 129 introduced a novel integrated microuidic sensor utilizing SERS, featuring a multifunctional nanocone array (MNA). This remarkable design enables the simultaneous identication of prostate-specic antigen (PSA) and thrombin.…”
Section: +mentioning
confidence: 99%
“…This amplication enables the examination of biomolecules such as small compounds, large protein molecules, and even cellular entities. 127,128 In this regard, Lu et al 129 introduced a novel integrated microuidic sensor utilizing SERS, featuring a multifunctional nanocone array (MNA). This remarkable design enables the simultaneous identication of prostate-specic antigen (PSA) and thrombin.…”
Section: +mentioning
confidence: 99%
“…Lu et al developed a new and versatile nanocone array that serves as a solid immunoassay plate and SERS substrate. 320 The nanocone array is coated with a thin Au film, which enhances the surface area and enables efficient antigen capture and conjugation with capture aptamers. This innovative technology enables the simultaneous detection of PSA and thrombin.…”
Section: Applications Of Sers In Disease Diagnosticsmentioning
confidence: 99%
“…SVM in combination with SERS has been used for the early detection of oral cancer among patients using serum and saliva samples and achieved an accuracy of 80% [ 227 ]. Prostate cancer has been extensively studied and successfully identified using different techniques, such as serum analysis combined with PCA-SVM [ 228 ]; detection of prostate specific antigens [ 229 , 230 , 231 , 232 ]; EVs combined with CNN [ 230 ]; miRNAs [ 233 ]; different multivariate techniques, e.g., PCA-LDA and PCA-SVM [ 234 ]; and urine profiling [ 235 ].…”
Section: Sers For Disease Diagnosismentioning
confidence: 99%